JC: Blood Products in Trauma – What’s the Best (I)TACTIC?

Bleeding trauma patients present a couple of challenges to us in the Emergency Department. Increasingly, our aging population continues to engage in energetic daily pursuits while increasing numbers are prescribed newer direct oral anticoagulant treatments

September Round Up Podcast

Welcome to our audio round up of everything on the blog during September. It’s been a relatively quiet on the blog post this month, but we chat through not only blogposts on the REMAP-CAP trial,

VTE and COVID-19: Would you like to know more?

That’s a leading question. Of course you would.  Who wouldn’t want to know more about a disease that has killed >1 million people to date, worldwide. Who wouldn’t want to know more about the thromboembolic risk associated

JC: Hydroxychloroquine in the the treatment of hospitalised COVID19 patients.

We previously covered the RECOVERY trial press release on the use of HCQ for hospitalised patients with COVID19. This is a UK based platform trial (more on this later) looking at patients admitted to hospital

JC: Antibiotics or Surgery for appendicitis.

Appendicitis is a common problem in the emergency department, and for many years the standard of care has been to perform surgery to resolve it. When I trained in surgery (before transferring to EM) this

Be a better Resuscitationist at #iMEDconference12

This week I am joining the iMED conference 12.0 in Lisbon, Portugal, except I’m not really as I am in my office here in Manchester as a result of the COVID19 pandemic. Lisbon is a

JC: Can we give tranexamic acid (TXA) via the IM route? St Emlyn’s

Tranexamic Acid (TXA) is a mainstay of trauma management. CRASH 2 (2) demonstrated its effectiveness in bleeding patients and CRASH 3 (1,5) (in my opinion) showed that we should also be using it in mild/moderate

CODA

CODA ZERO update: Gender and Ethics

This week I should be on my way to Australia for the CODA Change conference. For obvious reasons I am not going and am sat at home in Manchester enjoying the last remnants of the

JC: ISARIC. Possibly The Best COVID-19 Risk Prediction Tool To Date

Has your department been relying on clinical gestalt to risk stratify patients, perhaps using something you heard or read about in a short paper (perhaps Twitter), maybe something like post-exertional oxygenation has caught your eye,

JC: TXA in severe head injury. St Emlyn’s

Our post on the CRASH-3 trial, an RCT examining the use of TXA in head injury, was arguably our most controversial of 2019 (1). Our view was that the evidence was not entirely definitive, but


Browse Categories

Translate »